Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred Saad

Showing results (371-380 of 1,126) with videos related to

Pageof 113
Sort By:
Cancer Causes & Control : CCC|February 9, 2020
The effect of age on cancer-specific mortality in patients with prostate cancer: a population-based study across all stagesSophie Knipper, Angela Pecoraro, Carlotta Palumbo, et al.
Cancers|April 3, 2021
Elevated Expression of Glycerol-3-Phosphate Phosphatase as a Biomarker of Poor Prognosis and Aggressive Prostate CancerMohamed Amine Lounis, Veronique Ouellet, Benjamin Péant, et al.
European Urology Oncology|July 10, 2022
Addition of Docetaxel to Androgen Receptor Axis-targeted Therapy and Androgen Deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer: A Network Meta-analysisSoumyajit Roy, Rashid Sayyid, Fred Saad, et al.
Cancers|October 14, 2023
Relugolix vs. Leuprolide Effects on Castration Resistance-Free Survival from the Phase 3 HERO Study in Men with Advanced Prostate CancerFred Saad, Daniel J George, Michael S Cookson, et al.
Endocrine|February 24, 2020
Small adrenal incidentaloma becoming an aggressive adrenocortical carcinoma in a patient carrying a germline APC variantNadia Gagnon, Pascale Boily, Catherine Alguire, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 11, 2019
Comprehensive analysis of in-hospital delirium after major surgical oncology procedures: A population-based studyMarco Bandini, Michele Marchioni, Felix Preisser, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 10, 2018
Prognostic and predictive clinical factors in patients with metastatic castration-resistant prostate cancer treated with cabazitaxelDaniel W Yokom, John Stewart, Nimira S Alimohamed, et al.
Cancer|September 22, 2007
A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancerMichael A Carducci, Fred Saad, Per-Anders Abrahamsson, et al.
European Urology Oncology|May 19, 2019
The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American PatientsMarco Bandini, Felix Preisser, Sebastiano Nazzani, et al.
Journal of Geriatric Oncology|April 24, 2019
The effect of age and comorbidities on early postoperative complications after radical cystectomy: A contemporary population-based analysisElio Mazzone, Felix Preisser, Sebastiano Nazzani, et al.
Pageof 113

Showing results (371-380 of 1,126) with videos related to

Sort By:
Pageof 113
Cancer Causes & Control : CCC|February 9, 2020
The effect of age on cancer-specific mortality in patients with prostate cancer: a population-based study across all stagesSophie Knipper, Angela Pecoraro, Carlotta Palumbo, et al.
Cancers|April 3, 2021
Elevated Expression of Glycerol-3-Phosphate Phosphatase as a Biomarker of Poor Prognosis and Aggressive Prostate CancerMohamed Amine Lounis, Veronique Ouellet, Benjamin Péant, et al.
European Urology Oncology|July 10, 2022
Addition of Docetaxel to Androgen Receptor Axis-targeted Therapy and Androgen Deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer: A Network Meta-analysisSoumyajit Roy, Rashid Sayyid, Fred Saad, et al.
Cancers|October 14, 2023
Relugolix vs. Leuprolide Effects on Castration Resistance-Free Survival from the Phase 3 HERO Study in Men with Advanced Prostate CancerFred Saad, Daniel J George, Michael S Cookson, et al.
Endocrine|February 24, 2020
Small adrenal incidentaloma becoming an aggressive adrenocortical carcinoma in a patient carrying a germline APC variantNadia Gagnon, Pascale Boily, Catherine Alguire, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 11, 2019
Comprehensive analysis of in-hospital delirium after major surgical oncology procedures: A population-based studyMarco Bandini, Michele Marchioni, Felix Preisser, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 10, 2018
Prognostic and predictive clinical factors in patients with metastatic castration-resistant prostate cancer treated with cabazitaxelDaniel W Yokom, John Stewart, Nimira S Alimohamed, et al.
Cancer|September 22, 2007
A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancerMichael A Carducci, Fred Saad, Per-Anders Abrahamsson, et al.
European Urology Oncology|May 19, 2019
The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American PatientsMarco Bandini, Felix Preisser, Sebastiano Nazzani, et al.
Journal of Geriatric Oncology|April 24, 2019
The effect of age and comorbidities on early postoperative complications after radical cystectomy: A contemporary population-based analysisElio Mazzone, Felix Preisser, Sebastiano Nazzani, et al.
Pageof 113